These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18367765)

  • 1. Management of steroid sensitive nephrotic syndrome: revised guidelines.
    ; Bagga A; Ali U; Banerjee S; Kanitkar M; Phadke KD; Senguttuvan P; Sethi S; Shah M
    Indian Pediatr; 2008 Mar; 45(3):203-14. PubMed ID: 18367765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised guidelines for management of steroid-sensitive nephrotic syndrome.
    Bagga A
    Indian J Nephrol; 2008 Jan; 18(1):31-9. PubMed ID: 20368921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and management of steroid-sensitive nephrotic syndrome.
    Hodson EM; Alexander SI
    Curr Opin Pediatr; 2008 Apr; 20(2):145-50. PubMed ID: 18332709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil
    Ehren R; Benz MR; Doetsch J; Fichtner A; Gellermann J; Haffner D; Höcker B; Hoyer PF; Kästner B; Kemper MJ; Konrad M; Luntz S; Querfeld U; Sander A; Toenshoff B; Weber LT;
    BMJ Open; 2018 Oct; 8(10):e024882. PubMed ID: 30309995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J; Kryński J
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
    BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy: Maintenance of steroid-free remission in nephrotic syndrome.
    Deegens JK; Wetzels JF
    Nat Rev Nephrol; 2015 Oct; 11(10):569-70. PubMed ID: 26195145
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P; Frey MA; Deschênes G
    Arch Pediatr; 2005 Mar; 12(3):305-15. PubMed ID: 15734130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
    Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.